Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lissoni

Showing results (91-100 of 287) with videos related to

Pageof 29
Sort By:
Journal of Biological Regulators and Homeostatic Agents|October 1, 1990
Effect of mastectomy versus mastectomy plus adjuvant ovariectomy on prolactin response to TRH in breast cancerD Ayala, P Lissoni, C Archili, et al.
Tumori|April 30, 1992
Intracavitary administration of interleukin-2 as palliative therapy for neoplastic effusionsP Lissoni, S Barni, A Ardizzoia, et al.
The International Journal of Biological Markers|November 24, 1999
IL-2 immunotherapy-induced increase in IL-12 blood concentrations may depend on an increase in circulating dendritic cell numberP Lissoni, R Bucovec, S Meregalli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 1995
Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin-2P Lissoni, S Barni, G Tancini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2P Lissoni, E Tisi, F Brivio, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1997
Anticancer neuroimmunomodulation by pineal hormones other than melatonin: preliminary phase II study of the pineal indole 5-methoxytryptophol in association with low-dose IL-2 and melatoninP Lissoni, L Fumagalli, F Paolorossi, et al.
The International Journal of Biological Markers|July 1, 1989
The pineal gland and breast cancer: serum levels of melatonin in patients with mammary tumors and their relation to clinical characteristicsS Barni, P Lissoni, A Sormani, et al.
Minerva Pediatrica|October 31, 1982
[The lipid profile and nephelometry in obesity in children and juveniles]M Resentini, G Canto, P Lacqua, et al.
Tumori|December 31, 1994
A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancerP Lissoni, S Meregalli, V Fossati, et al.
Oncology|January 1, 1996
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy aloneP Lissoni, S Meregalli, L Nosetto, et al.
Pageof 29

Showing results (91-100 of 287) with videos related to

Sort By:
Pageof 29
Journal of Biological Regulators and Homeostatic Agents|October 1, 1990
Effect of mastectomy versus mastectomy plus adjuvant ovariectomy on prolactin response to TRH in breast cancerD Ayala, P Lissoni, C Archili, et al.
Tumori|April 30, 1992
Intracavitary administration of interleukin-2 as palliative therapy for neoplastic effusionsP Lissoni, S Barni, A Ardizzoia, et al.
The International Journal of Biological Markers|November 24, 1999
IL-2 immunotherapy-induced increase in IL-12 blood concentrations may depend on an increase in circulating dendritic cell numberP Lissoni, R Bucovec, S Meregalli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 1995
Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin-2P Lissoni, S Barni, G Tancini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2P Lissoni, E Tisi, F Brivio, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1997
Anticancer neuroimmunomodulation by pineal hormones other than melatonin: preliminary phase II study of the pineal indole 5-methoxytryptophol in association with low-dose IL-2 and melatoninP Lissoni, L Fumagalli, F Paolorossi, et al.
The International Journal of Biological Markers|July 1, 1989
The pineal gland and breast cancer: serum levels of melatonin in patients with mammary tumors and their relation to clinical characteristicsS Barni, P Lissoni, A Sormani, et al.
Minerva Pediatrica|October 31, 1982
[The lipid profile and nephelometry in obesity in children and juveniles]M Resentini, G Canto, P Lacqua, et al.
Tumori|December 31, 1994
A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancerP Lissoni, S Meregalli, V Fossati, et al.
Oncology|January 1, 1996
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy aloneP Lissoni, S Meregalli, L Nosetto, et al.
Pageof 29